Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
86.45 USD | -0.91% | -5.43% | +13.38% |
Apr. 17 | Baird Adjusts Edwards Lifesciences Price Target to $102 From $100 | MT |
Apr. 17 | Leerink Partners Adjusts Edwards Lifesciences' Price Target to $93 From $96, Keeps Market Perform Rating | MT |
Chart calendar Edwards Lifesciences Corporation
Upcoming events on Edwards Lifesciences Corporation
Past events on Edwards Lifesciences Corporation
2024-03-05 10:30 am | TD Cowen Health Care Conference |
2024-02-06 05:00 pm | Q4 2023 Earnings Call |
2024-02-06 04:15 pm | Q4 2023 Earnings Release |
2024-01-09 02:15 pm | JPMorgan Healthcare Conference |
2023-12-07 11:30 am | Investor Conference |
2023-10-26 05:30 pm | Analyst & Investor Meeting - TMTT Q&A Session at TCT |
2023-10-25 | Transcatheter Cardiovascular Therapeutics Scientific Symposium |
2023-10-25 05:00 pm | Q3 2023 Earnings Call |
2023-10-25 04:15 pm | Q3 2023 Earnings Release |
2023-10-24 09:00 pm | Analyst & Investor Meeting - TAVR Q&A Session at TCT |
2023-09-07 11:00 am | Wells Fargo Healthcare Conference |
2023-07-26 05:00 pm | Q2 2023 Earnings Call |
2023-07-26 04:15 pm | Q2 2023 Earnings Release |
2023-05-16 | American Association for Thoracic Surgery Meeting |
2023-05-11 01:00 pm | Annual General Meeting |
2023-05-06 | American Association for Thoracic Surgery Meeting |
2023-04-26 05:00 pm | Q1 2023 Earnings Call |
2023-04-26 04:15 pm | Q1 2023 Earnings Release |
2023-03-07 10:30 am | Cowen Health Care Conference |
2023-01-31 05:00 pm | FY 2022 Earnings Call |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 4 348 4 316 0.73% | 4 386 4 385 0.02% | 5 233 5 255 -0.43% | 5 382 5 365 0.32% | 6 005 5 972 0.55% | 6 518 |
EBITDA Million USD | Released Forecast Spread | 1 406 1 425 -1.36% | 1 429 1 444 -1% | 1 729 1 766 -2.07% | 1 936 1 942 -0.31% | 1 879 1 904 -1.34% | 2 098 |
EBIT Million USD | Released Forecast Spread | 1 316 1 328 -0.86% | 1 322 1 334 -0.9% | 1 595 1 622 -1.73% | 1 797 1 789 0.4% | 1 734 1 754 -1.15% | 1 925 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 1 167 1 180 -1.14% | 917 903 1.51% | 1 702 1 585 7.4% | 1 767 1 740 1.55% | 1 598 1 658 -3.62% | 1 924 |
Net income Million USD | Released Forecast Spread | 1 047 1 031 1.59% | 823 819 0.5% | 1 503 1 437 4.63% | 1 522 1 498 1.56% | 1 402 1 399 0.22% | 1 622 |
EPS USD | Released Forecast Spread | 1,64 1,63 0.61% | 1,30 1,32 -1.82% | 2,38 2,30 3.3% | 2,44 2,39 2.16% | 2,30 2,29 0.34% | 2,68 |
Announcement Date | 30/01/20 | 27/01/21 | 26/01/22 | 31/01/23 | 06/02/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 1 330 1 354 -1.8% | 1 341 1 311 2.29% | 1 374 1 399 -1.83% | 1 319 1 333 -1.03% | 1 348 1 329 1.43% | 1 460 1 394 4.69% | 1 530 1 505 1.67% | 1 481 1 480 0.05% | 1 534 1 499 2.34% | 1 573 | 1 645 | 1 613 | 1 682 | 1 718 |
EBITDA Million USD | Released Forecast Spread | 398 432 -7.8% | 479 452 6.08% | 480 496 -3.14% | 493 487 1.12% | 484 481 0.7% | 469 471 -0.4% | 486 495 -1.88% | 459 458 0.08% | 465 489 -4.95% | 494 | 527 | 520 | 547 | 554 |
EBIT Million USD | Released Forecast Spread | 365 395 -7.49% | 445 413 7.57% | 446 460 -3.13% | 457 453 0.96% | 449 443 1.21% | 434 434 0.02% | 450 456 -1.38% | 422 419 0.64% | 428 446 -3.95% | 450 | 486 | 479 | 504 | 510 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 376 325 15.78% | 436 397 9.9% | 465 435 6.79% | 407 436 -6.64% | 459 436 5.36% | 399 431 -7.62% | 339 449 -24.63% | 439 425 3.25% | 422 445 -5.24% | 450 | 489 | 485 | 508 | 522 |
Net income Million USD | Released Forecast Spread | 335 317 5.79% | 374 343 8.94% | 406 389 4.52% | 344 383 -10.36% | 398 375 6.2% | 341 371 -8.1% | 307 375 -18.06% | 385 345 11.45% | 370 385 -3.97% | 379 | 409 | 407 | 427 | 432 |
EPS USD | Released Forecast Spread | 0,53 0,52 2.45% | 0,59 0,56 5.36% | 0,65 0,62 5.69% | 0,55 0,61 -10.33% | 0,65 0,60 8.33% | 0,56 0,60 -7.24% | 0,50 0,61 -17.89% | 0,63 0,56 12.17% | 0,61 0,63 -3.13% | 0,63 | 0,67 | 0,67 | 0,70 | 0,71 |
Announcement Date | 26/01/22 | 26/04/22 | 28/07/22 | 27/10/22 | 31/01/23 | 26/04/23 | 26/07/23 | 25/10/23 | 06/02/24 | - | - | - | - | - |
Past sector events for Edwards Lifesciences Corporation
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- EW Stock
- Calendar Edwards Lifesciences Corporation